Monday 25 June 2018

Pharmaceutical Glass Packaging Market Size Likely To Reach A Valuation Of Around USD 22.05 Billion By 2025 : Grand View Research, Inc.


The global pharmaceutical glass packaging market size is expected to reach USD 22.05 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 6.3% during the forecast period. Spiraling sale of generic drugs in developed as well as developing economies is projected to drive the demand for pharmaceutical glass packaging. Glass has a well-defined supply chain in the pharmaceutical industry and is traditionally used for parenteral drug packaging. Extensive R&D is being conducted by product manufacturers in order to minimize negative aspects of glass, such as high susceptibility to breaking and delamination, as well as to improve the quality & efficacy of the product.
The pharmerging market is anticipated to witness phenomenal growth owing to favorable government policies and increased healthcare awareness. Governments of developing nations are expanding their public or private healthcare coverage and simultaneously making efforts to minimize out-of-pocket medical expenses for the consumers. Increasing government efforts to reduce healthcare cost and promotion of low-cost generic drugs are estimated to fuel the utilization of glass packaging over the coming years.
Emergence of novel drugs such as cancer drugs and bio-therapeutics is likely to help the market gain traction over the coming years. In an effort to safeguard patient health, guidelines for packaging of biological drugs have been made highly stringent, which necessitates constant development in the field of pharmaceutical packaging. Aforementioned factors promote manufacturers to adopt advanced techniques, thereby driving the market.
In primary pharmaceutical packaging, glass has an advantage over plastic as plastic production requires raw materials such as polyethylene, polypropylene, and polystyrene, which are largely dependent on fluctuating petroleum industry. Manufacturers use soda lime, quartz, and other additives for manufacturing glass. These raw materials are easily available in the market by numerous suppliers. Recent developments in the pharmaceutical glass packaging include launch of Gx Baked-On RTF and an Omniflex plunger, a prefilled syringe, by Gerresheimer AG in September 2017. This technology has the ability to minimize particle loads and meet strict requirements for therapeutic protein products for better deliver of drug. 
Full research report on pharmaceutical glass packaging market analysis:
https://www.grandviewresearch.com/industry-analysis/pharmaceutical-glass-packaging-market

Further Key Findings from the Report Suggest:
·         The vials segment is projected to ascend at a CAGR of 6.9% in terms of revenue over the forecast period
·         The bottles segment dominated the global pharmaceutical glass packaging market in 2016 in terms of revenue and is anticipated to witness a CAGR of 4.7% from 2017 to 2025 owing to high penetration of plastics in the manufacturing of bottles
·         The generic drug segment accounted for 69.8% of the market in 2016 due to rapidly increasing manufacturing volumes of generic drugs in emerging economies
·         Europe is expected to witness considerable growth during the forecast period owing to constant development in the medical field aimed at improving health and quality of life
·         Some of the key companies present in the market are Corning Incorporated; Gerresheimer AG; Nipro Pharmapackaging; SCHOTT AG; Şişecam Group; Arab Pharmaceutical Glass Co.; Beatson Clark; Stevanato Group; and Owens-Illinois, Inc.                                                                                   
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global pharmaceutical glass packaging market on the basis of product, drug type, and region:
Pharmaceutical Glass Packaging Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Vials
o    Small vials (<30ml)
o    Large vials (>30ml)
·         Bottles
o    Small Bottles (< 1000 ml)
o    Large Bottles (> 1000 ml)
·         Cartridges & Syringes
·         Ampoules
Pharmaceutical Glass Packaging Drug Type Outlook (Revenue, USD Million, 2014 - 2025)
·         Generic
·         Branded
·         Biologic
Pharmaceutical Glass Packaging Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
·         Europe
o    Germany
o    U.K.
o    France
o    Spain
o    Italy
·         Asia Pacific
o    China
o    India
o    Japan
o    South Korea
·         Central & South America
o     Brazil
·         Middle East & Africa
View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-pharmaceutical-glass-packaging-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: 
www.grandviewresearch.com

Thursday 21 June 2018

Alopecia market is expected to reach over USD 11.8 Billion by 2024 : Grand View Research, Inc.

The global alopecia market is expected to reach over USD 11.8 Billion by 2024 according to a new report published by Grand View Research, Inc. The increased healthcare expenditure and the resultant augmentation of healthcare facilities, globally, are the key drivers of the alopecia treatment market. 
Additionally, the increasing awareness amongst individuals pertaining to the availability of the treatment options can be attributed to the favorable initiatives taken by organizations such as the National Alopecia Areata Foundation (NAAF) and the American Hair Loss Association. The increasing R&D investments pertaining to the development of novel therapeutics for the treatment of alopecia is expected to boost the usage rates. 
International conferences are held by the NAAF for individuals suffering from alopecia, irrespective of their age, furthermore, NAAF also promotes research by bringing together scientists from all over the world. The 31st National Conference of NAAF will be held in Washington DC from 14th July to 16th July, 2016. 
The FDA approval of the Janus kinase inhibitors (JAK) drugs that stimulate the growth of hair follicles with minimal side effects is further expected to boost the alopecia treatment market. The Children Alopecia Project by AHLA is dedicated towards making investments in Children Support Groups, which provide funding for children who cannot afford to attend the NAAF Conference and promote research and development activities in alopecia treatment for children. 
Bald Truth is a radio program that is involved in spreading awareness about the different types of alopecia affecting people and about the varied products used for the effective treatment of alopecia that are currently available in the market. Rapunzel Project is another initiative by AHLA that is dedicated towards preventing hair loss in chemotherapy patients.  
Full research report on alopecia market analysis:
http://www.grandviewresearch.com/industry-analysis/alopecia-market

Further key findings from the study suggest:
·         In 2015, topical treatment accounted for over USD 2.8 billion in global alopecia treatment market. The key factors responsible for the large share of topical products include easy application, non-invasive nature, and high awareness amongst the population pertaining to the available therapeutics. The top brands of topical solution are Keranique, Phytoworx, Ultrax, and Nioxin.
·         The patent expiration of majority of the drugs, such as Propecia & Rogaine and the FDA approval gained for the JAK drugs, in 2015, which is an immunosuppresant with minimal side effects are expected to boost the alopecia treatment market during the forecast period.
·         In 2015, the dominant gender segment for the alopecia market were women that generated a revenue of about USD 4.03 billion and is expected to grow at a lucrativerate over the forecast period. The increasing awareness amongst women about alopecia and the emphasis laid upon appearance by them,are the key drivers of this segment.
·         North America was the highest revenue generating region with the market valued at over USD 2.49 billion in 2015. The increasing number of consumer disposable incomes, the introduction of new drugs, and the favorable initiatives taken by the pertinent organizations namely, NAAF and AHLA, are the key factors for the region’s large share.
·         Key players operating in the market are Cipla, Merck & Co., Johnson & Johnson, Lifes2good, Dr. Reddy’s Laboratories, Sun Pharma, Kirkland Signature, Alpecin, Vitabiotics, and Phyto Ales Group. 
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global alopecia market on the basis of treatment and gender:
Global alopecia treatment outlook, by revenue (USD Million, 2016 - 2024)
·         Oral
·         Topical
·         Others
Global alopecia gender outlook, by revenue (USD Million, 2016 - 2024)
·         Men
·         Women
Global alopecia regional outlook, by revenue (USD Million, 2016 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-alopecia-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: 
www.grandviewresearch.com



Aesthetic Medicine Market expected to reach USD 11.9 billion by 2022 : Grand View Research, Inc.


The global aesthetic medicine market is expected to reach USD 11.9 billion by 2022, according to a new report by Grand View Research, Inc. Some key drivers of the market include growth in aging population, increasing disposable income, and increasing awareness about the efficacy of aesthetic treatments. 
People aged between 25 to 65 years have prominent aging signs such as wrinkles, fine lines, and dark spots. For instance, according to the CIA World Fact Book, approximately 47.2% of the total population of China was aged between 25 to 54 years in 2014. Growth in geriatric population is likely to boost demand via widening the consumer base. 
Moreover, the need for improved aesthetics in the growing working class population is likely to boost usage rates over the forecast period. For instance, according to sources, the U.S. alone had a working population of 139.206 million in 2011. With improving employment rates especially in the emerging markets, the demand for aesthetic medicine is going to advance over the forecast period. 
However, the presence of stringent regulatory framework to ensure product safety and efficacy is one of the prime factors limiting the growth of the global aesthetic medicine market. Moreover, surgical and minimally invasive procedures require skilled professionals. This coupled with the growing overall treatment cost, is expected to restraint market growth.
Full research report on aesthetic medicine market analysis: http://www.grandviewresearch.com/industry-analysis/medical-aesthetics-market

Further key findings from the study suggest:
·         Anti-wrinkle products accounted for the largest market share of 50.2% in 2014 owing to high consumer awareness levels regarding product availability, affordable cost, and high efficacy rates
·         The segment is expected to maintain its dominance throughout the forecast period. Minimally invasive technique, lesser side effects, and better results are some factors that are expected to drive the anti-wrinkle market towards expedited growth
·         Botulinum toxin is one of the oldest anti-wrinkle products available in the market. Therefore, awareness about the effectiveness of this product is high as compared to other products, resulting in the segment dominating in terms of revenue share.
·         Hyaluronic acid owing to, low side effects and high efficacy rates also accounted for a large market share in 2014
·         Clinics and beauty centers, was the largest end-use segment in 2014 as majority of the techniques demand skilled professionals to perform the procedure. Moreover, stringent regulatory guidelines limit the use of high-risk devices and treatments to professionals. As a result, the clinics and beauty center segment is expected to maintain its market position throughout the forecast period.
·         Asia pacific accounted for the largest market share of around 32.5% in 2014. Growing penetration of the technologically advanced products, cheaper treatment cost, and presence of skilled professionals are some factors driving regional growth. Moreover, growing popularity of the emerging Asia Pacific countries as medical tourism hubs will boost demand over the forecast period.
·         The presence of a large target population pool in China and India between 25 to 65 years coupled with rapidly increasing disposable income and improving standards of living is spurring the demand for aesthetic medicine in this region.
·         Some key players operating in the global market include Allergan, Inc., Alma Laser, Cynosure, Galderma S.A., Lumenis, Johnson and Johnson, Solta Medical, Inc. and Syneron Medical Ltd. 
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the aesthetic medicine market on the basis of product type, end-use, and region:
Global Aesthetic Medicine Product Outlook, 2012 - 2022 (USD Million)
·         Energy Based Devices
o    Aesthetic Laser Devices
o    Body Contouring Devices
o    Microdermabrasion
o    Ultrasound
·         Implants
·         Anti-wrinkle products
o    Botulinum toxin
o    Dermal Fillers
o    Chemical Peel
Global Aesthetic Medicine End-use Outlook, 2012 - 2022 (USD Million)
·         Clinics and Beauty Centers
·         Home Use
Aesthetic Medicine Regional Outlook, 2012 - 2022 (USD Million)
·         North America
o    U.S. Aesthetic Medicine Marketby Product Type
o    Canada Aesthetic Medicine Marketby Product Type
o    U.S. Aesthetic Medicine Marketby End-use
o    Canada Aesthetic Medicine Marketby End-use
·         Europe
o    Germany Aesthetic Medicine Marketby Product Type
o    France Aesthetic Medicine Marketby Product Type
o    Germany Aesthetic Medicine Marketby End-use
o    France Aesthetic Medicine Marketby End-use
·         Asia Pacific
o    South Korea Aesthetic Medicine Marketby Product Type
o    Japan Aesthetic Medicine Marketby Product Type
o    South Korea Aesthetic Medicine Marketby End-use
o    Japan Aesthetic Medicine Marketby End-use
·         Latin America
o    Brazil Aesthetic Medicine Marketby Product Type
o    Mexico Aesthetic Medicine Marketby Product Type
o    Brazil Aesthetic Medicine Marketby End-use
o    Mexico Aesthetic Medicine Marketby End-use
·         MEA
o    South Africa Aesthetic Medicine Marketby Product Type
o    South Africa Aesthetic Medicine Marketby End-use
View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-aesthetic-medicine-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: 
www.grandviewresearch.com